TORONTO and SAN DIEGO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Triphase Accelerator, a private drug development company dedicated to advancing novel compounds through clinical proof-of-concept, today ...
Celgene, already heavily involved with the biotech, has announced a deeper tie-up with private co Triphase Accelerator that sees it buy into its proteasome inhibitor. Under the deal, financial details ...
Dr Shrilakshmi Desiraju, the co-founder of pharmaceutical research and development startup Triphase, exemplifies all the qualities essential in an entrepreneur. In this conversation with YourStory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results